Sometimes important scientific discoveries occur secondhand. For Parkinson's disease, that may be exactly the case.

Widely given to patients with type 2 diabetes, metformin has been linked to reducing the risk for many types of cancers. The medication, however, may not be effective against one certain cancer.

People with type 2 diabetes have higher cancer risks than the general population. The link may have to do with how diabetes affects the metabolism. Diabetes medications may also figure into the equation.

Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.

While several medications are already on the market to treat diabetes, not all patients have the desired control over their blood sugar levels. Alogliptin may offer a fresh option.

There are many factors to think about when prescribing drugs to diabetes patients. One of these factors is the cancer risk of a particular drug; or in some cases, the cancer-preventing powers of that drug.

There are two kinds of cholesterol: HDL and LDL cholesterol. HDL cholesterol is known as the "good" cholesterol, and it may be beneficial for patients with diabetes.

If you've been taking Actos or Takeda for more than a year to control your type 2 diabetes, you will want to be in touch with your family physician or endocrinologist. A link with bladder cancer has been discovered.

Actos and Competact, two top-selling type 2 diabetes drugs, have been pulled off the markets in France and Germany following studies linking the medications to bladder cancer.

Around the world, millions of people face an increased risk of early death from diabetes and cardiovascular diseases related to diabetes. Researchers found that poor diagnoses and ineffective treatment are to blame.